BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 29
• 30

• Press Releases

  Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

  December 24, 2025

   · 

  12 min read
• Press Releases

  Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 Initiation of ENV-6946, a First-in-Class Oral “Multi-Biologic in a Pill” for Inflammatory Bowel Disease

  December 24, 2025

   · 

  4 min read
• Press Releases

  Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update

  December 24, 2025

   · 

  11 min read
• Press Releases

  Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change

  December 24, 2025

   · 

  6 min read
• Press Releases

  Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors

  December 24, 2025

   · 

  3 min read
• Press Releases

  CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements

  December 24, 2025

   · 

  6 min read
• Press Releases

  LSL PHARMA GROUP ANNOUNCES CLOSING OF THE ACQUISITION OF JUNO OTC AND FINAL $2M CLOSING OF UPSIZED $12M OFFERING

  December 24, 2025

   · 

  6 min read
• Press Releases

  Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn

  December 24, 2025

   · 

  4 min read
• Press Releases

  Solventum Completes Acquisition of Acera Surgical

  December 24, 2025

   · 

  6 min read
• Press Releases

  SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug ‘SNB-101' on Gastric Cancer.

  December 24, 2025

   · 

  3 min read